Anemia in chronic heart failure;Anemia en la insuficiencia cardiaca crónica

Revista Clinica Espanola

Volumn 211, Issue 7, 2011, Pages 354-359

  Grau Amoros J ^a   Formiga, F ^b   Urrutia, A ^c  

^a Hospital Municipal de Badalona   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Anemia; Heart failure; Treatment

Indexed keywords

ERYTHROPOIETIN;

AGED; ANEMIA; CASE REPORT; CLINICAL PRACTICE; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; OUTPATIENT CARE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 79959347837     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2011.03.013     Document Type: Article

References (29)

1. Grupo de Trabajo de Insuficiencia Cardiaca de la Sociedad Española de Medicina Interna (SEMI). La insuficiencia cardiaca en los servicios de medicina interna (estudio SEMI-IC). Med Clin (Barc). 2002;118:605-10.
2. NKF-DOQI. Clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis. 1997;30:S194-240.
3. Grau-Amorós J, Formiga F, Jordana-Comajuncosa R, Urrutia A, Aramburu Bodas O, Ceresuela LM. Prevalencia de la anemia en la insuficiencia cardiaca. Resultados el estudio GESAIC. Rev Clin Esp. 2008;208:211-5.
4. Somaratne JB, Berry C, McMurray JJV, Poppe KK, Doughty RN, Whalley GA. The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail. 2009;11:855-62.
5. Peterson PN, Magid DJ, Lyons EE, Clarke CL, Zeng C, Fitzgerald A, et al. Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure. Am Heart J. 2010;159:81-9.
6. Anand IS, Kuskowski MA, Rector TS, Florea VG, Glazer RD, Hester A, et al. Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure Results From Val-HeFT. Circulation. 2005;112:1121-7. (Pubitemid 41216118)
7. Komajda M, Ander SD, Charlesworth A, Okonko D, Metra M, Di Lenarda A, et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J. 2006;27:1440-6. (Pubitemid 43998078)
8. Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic Heart failure. J Am Coll Cardiol. 2008;51:577-8.
9. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-9. (Pubitemid 36135215)
10. Drakos SG, Anastasiou-Nana MI, Malliaras KG, Nanas JN. Anemia in chronic heart failure. Congest Heart Fail. 2009;15:87-92.
11. Jelkman W. Erythropoietin after a century of research: younger than ever. Eur J Haematol. 2007;78:183-205.
12. Belonje AM, Voors AA, van der Meer P, van Gilst WH, Jaarsma T, van Veldhuisen DJ. Endogenous erythropoietin and outcome in heart failure. Circulation. 2010;121:245-51.
13. Kazory A, Ross EA. Anemia: The Point of Convergence or Divergence for Kidney Disease and Heart Failure? J Am Coll Cardiol. 2009;53:639-47.
14. Grau-Amorós J, Formiga F, Jordana-Comajuncosa R, Urrutia A, Arias Jiménez JL, Salvador Mínguez JP. Etiología y tratamiento de la anemia en la insuficiencia cardíaca. Estudio GESAIC. Med Clin (Barc). 2009;132:447-53.
15. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, et al. Anemia and Mortality in Heart Failure Patients. A Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2008;52:818-27.
16. Young JB, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Relation of Low Hemoglobin and Anemia to Morbidity and Mortality in Patients Hospitalized With Heart Failure (Insight from the OPTIMIZE-HF Registry). Am J Cardiol. 2008;101:223-30.
17. Adams KF, Piña IL, Ghali JK, Wagoner LE, Dunlap SH, Schwartz TA, et al. Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure. Am Heart J. 2009;158:965-71.
18. Wilson Tang WH, Tong W, Jain A, Francis GS, Harris CM, Young JB. Evaluation and Long-Term Prognosis of New-Onset, Transient, and Persistent Anemia in Ambulatory Patients With Chronic Heart Failure. J Am Coll Cardiol. 2008;51:569-76.
19. Miyagishima K, Hiramitsu S, Kimura H, Mori K, Yoda R, Kato S, et al. Influence of Cardio-Renal-Anemia Syndrome on the Outcome of Heart Failure. J Card Fail. 2009;15(7S):S162.
20. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872-80.
21. Garty M, Cohen E, Zuchenko A, Behar S, Boyko V, Lakobishvili Z, et al. Blood transfusion for acute decompensated heart failure-friend or foe? Am Heart J. 2009;158:653-8.
22. Anker SD, Comin J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. N Engl J Med. 2009;361: 2436-48.
23. Ajmera AV, Shastri GS, Gajera MJ, Judge TA. Suboptimal Response to Ferrous Sulfate in Iron-Deficient Patients Taking Omeprazole. Am J Ther. 2010 Dec 3.[Epub ahead of print].
24. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease. N Engl J Med. 2006;355:2085-98. (Pubitemid 44749317)
25. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, et al. Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia. N Engl J Med. 2006;355:2071-84. (Pubitemid 44749316)
26. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease. N Engl J Med. 2009;361:2019-32.
27. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet. 2007;369:381-8. (Pubitemid 46188479)
28. van der Meer P, Lock DJ, Januzzi JL, Bruggink-Andre de la Porte PW, Lipsic E, vanWijngaarden J, et al. Adequacy of endogenous erythropoietin levels. Eur Heart J. 2008;29:1510-5.
29. RED-HF Trial: Reduction of Events With Darbepoetin Alfa in Heart Failure Trial. Disponible en: http://clinicaltrials.gov/ct2/show/study/NCT00358215.